AR and neoplasm: This phenomenon suggests that resistance to ADT is not solely dependent on androgen levels but is instead mediated by a range of alternative mechanisms that enable the AR to maintain its function in driving tumor progression [2,13,14], including those driven by oxidative stress [15,16].